Changes in functional status after treatment of critical limb ischemia  by Frans, Franceline Alkine et al.
From
C
Auth
Add
Rep
C
(e
The
to
m
0741
Cop
httpChanges in functional status after treatment of
critical limb ischemia
Franceline Alkine Frans, MD,a,b Rosemarie Met, MD, PhD,a Mark J. W. Koelemay, MD, PhD,a
Shandra Bipat, PhD,b Marcel G. W. Dijkgraaf, PhD,c Dink A. Legemate, MD, PhD,a and
Jim A. Reekers, MD, PhD,b Amsterdam, The Netherlands
Objective: This study evaluated changes in functional status with the Academic Medical Center Linear Disability Score
(ALDS) and in quality of life with the Vascular Quality of Life Questionnaire (VascuQol) in patients treated for critical
limb ischemia (CLI).
Methods: We conducted a prospective observational cohort study in a single academic center that included consecutive
patients with CLI who presented between May 2007 and May 2010. The ALDS and VascuQol questionnaires were
administered before treatment (baseline) and after treatment at 6 and 12 months of follow-up. Changes in functional
status (ALDS) and quality of life (VascuQol) scores after 6 and 12 months, compared with baseline, were tested with the
appropriate statistical tests, with signiﬁcance set at P < .05.
Results: The study included 150 patients, 96 (64%) were men, and mean (6 standard deviation) age was 68.1 (612.4)
years. The primary treatment was endovascular in 98 (65.3%), surgical in 36 (24%), conservative in 11 (7.3%), or a major
amputation in ﬁve (3.3%). The ALDS was completed by 112 patients after 12 months. At that time, the median ALDS
score had increased by 10 points (median, 83; range, 12-89; P [ .001) in patients who achieved limb salvage, which
corresponds with more difﬁcult outdoor and indoor activities. In patients with a major amputation, the median ALDS
score decreased by 14 points (median, 55; range, 16-89; P [ .117) after 12 months, which corresponds with domestic
activities only. VascuQol scores improved signiﬁcantly in all separate domains for the limb salvage group (P < .001). All
VascuQol scores, except for the activity and social domains, increased signiﬁcantly after amputation.
Conclusions:Our study conﬁrms the clinical validity of the ALDS in patients treated for CLI and shows that it is a valuable
and sophisticated instrument to measure changes in functional status in these patients. (J Vasc Surg 2013;58:957-65.)Treatment of patients with critical limb ischemia (CLI)
is aimed at relief of ischemic pain and wound healing.
Whereas traditional outcomes such as bypass patency and
limb salvage are important to assess the effectiveness of
treatment for CLI, the importance of patient-reported
outcomes such as functional status (FS) and quality of life
(QOL) is increasingly recognized. QOL expresses the
patient’s perception of disease, along with expectations
and values, on mental, social, and physical functioning.
The Vascular Quality of Life Questionnaire (VascuQol) is
a reliable and valid instrument to assess QOL in patients
with peripheral arterial disease (PAD).1-3
Disability in performing activities is one of the domains
of QOL instruments.4 However, QOL instruments are not
designed to express the level of functioning, but to evaluate
the patient’s perception thereof. Disability is more closely
related to the disease than QOL, and as such, a more
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CLI are mainly conﬁned to gross measures such as ambu-
lation and residential status.4-7
The Academic Medical Center Linear Disability Score
(ALDS) is a more sophisticated instrument to measure
FS because it expresses FS in terms of activities of daily
life. The ALDS is a generic item bank that is able to
measure the disability status of patients with a broad range
of diseases.8-12 Scores range between 0 and 100 on a linear
scale, with higher scores corresponding with the ability to
perform more difﬁcult activities (Supplementary Table,
online only). Construct and clinical validity of the ALDS
have been proven in patients with intermittent claudication
and CLI.13,14 The ALDS has been found easy to use and
can be completed in a very short time,14 which not only
adds to its applicability in research but also to its use in daily
practice. The ALDS has been developed within the frame-
work of item response theory (IRT). Hence, its hierarchic
properties are well suited to assess the effect of treatment
over time and to compare different treatment modalities
and the difference in effects of treatment between hospitals.
FS and QOL indicators could aid clinical decision
making when physicians are confronted with the dilemma
of whether to perform a revascularization with a long
clinical course or to perform a primary amputation.
The aim of this study was to evaluate changes in FS
with the ALDS and to assess changes in QOL with the Vas-
cuQol in patients who were treated for CLI. A secondary
aim was to explore whether the ALDS and VascuQol
instruments could help identify subgroups of patients957
Fig 1. Academic Medical Center Linear Disability Score (ALDS)
and corresponding activities.
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revascularization.
METHODS
Study population and eligibility
After approval from the local Medical Ethical Committee,
we conducted a prospective observational cohort study in
which all consecutive patients with chronic CLI, who visited
our vascular surgery department between May 2007 and
May 2010, were invited to participate. Chronic CLI was
deﬁned as ischemic rest pain (Fontaine stage III), ulcers, or
gangrene (Fontaine stage IV) attributable toobjectivelyproven
arterial occlusive disease present for >2 weeks.15 The eligible
patients who were included gave written informed consent to
participate. Patients with insufﬁcient knowledge of the Dutch
language, an estimated life expectancy of <6 months, or who
were unable to give informed consent were excluded.
Treatment
Patients received treatment as agreed with their treat-
ing vascular surgeon, independent of the study. Patients
were treated by endovascular or surgical revascularization,
conservatively, or by primary major amputation. Endovas-
cular revascularization, when possible, is the preferred
ﬁrst-line treatment in our institution and comprised percu-
taneous transluminal angioplasty (PTA) and percutaneous
subintimal angioplasty (SA), with or without stent place-
ment. Surgical revascularization included bypass grafting
and endarterectomy.
Assessments
History and examination. Before treatment, we
recorded patient demographics, risk factors for atheroscle-
rosis, history of coronary heart disease, stroke, peripheral
vascular interventions, and major contralateral amputation.
The presence of rest pain or ischemic tissue lesions, self-
reported walking distance, ambulation, and residential status
were also recorded. Additional examinations included ankle-
brachial pressure index, toe pressure, and transcutaneous
oxygen pressure. The transcutaneous oxygen pressure
measurements were performed with a TCM4 transcutaneous
monitor connected to a combined transcutaneous oxygen
pressure electrode (Radiometer, Copenhagen, Denmark).
FS. The ALDS is a generic item bank, developed within
the framework of IRT, for measuring a patient’s ability to
perform basic and instrumental activities of daily life and
difﬁcult outdoor activities.8 The measurement properties
of each item from the item bank are known, enabling the
use of small sets of items tailored to the FS level of the
patients 8,9,16 The items are hierarchically ordered from
difﬁcult (such as “travel by local bus or tram”) to relatively
easy activities (such as “go to the toilet”). Responses to the
items are dichotomized into “I can carry out the activity
(but with difﬁculty)” and “I cannot carry out the activity.” If
a patient has never performed the activity or does not know
whether he or she is able to do so, the response “not
applicable” is recorded.17 The original units of the ALDSscale are (logistic) regression coefﬁcients, expressed in log-
its. These logits are linearly transformed into values between
0 and 100 to facilitate interpretation, with lower scores
corresponding with more disability (Fig 1).
ALDS outcome scores were calculated from patients’
responses to the individual items using a two-parameter
IRT model, based on previously published item properties
for “difﬁculty” and “discrimination” and algorithms imple-
mented in BILOG-MG 3.0 software. On the basis of clin-
ical relevance and adapted to the disability level of this
speciﬁc patient group in the current study, 27 items were
selected (Supplementary Table, online only). Although
ALDS outcomes scores are reported in the “Results” to
facilitate interpretation, all underlying statistical analyses
were performed at interval level of measurement with the
logits as the original units of the ALDS scale. The ALDS
was recorded by one of the investigators (F.F. or R.M.).
QOL. The VascuQol is a validated instrument with 25
items on ﬁve domains of Pain (four items), Activity (eight
items), Emotional (seven items), Symptoms (four items),
and Social (two items). Each item is rated as a 7-point
response scale, with a score of 1 the worst possible and
a score of 7 the best possible. The total average score is the
sum of the 25 item scores divided by 25. For each separate
domain, an average score can be calculated (sum of all
items of one domain divided by the number of items of
that domain). Thus, the overall score and the scores per
domain both range from 1 to 7.1-3 The VascuQol was sent
by postal mail and completed by the patients at home. All
patients were requested to complete the ALDS and Vas-
cuQol at baseline, before treatment, and again at 6 and
12 months of follow-up after treatment.
Limb salvage. Limb salvage was deﬁned as preserva-
tion of a limb, with or without a minor (transphalangeal
Fig 2. Flow diagram of study.
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deﬁned as amputations proximal to the ankle, including
below-knee amputation, through-knee amputation, and
above-knee amputation.
Statistical analysis
Patient characteristics and outcome scores were
summarized using descriptive statistics. Changes in FS
(ALDS) and QOL (VascuQol) scores after 6 and 12
months compared with baseline were tested with a linear
mixed model for normally distributed data or the Fried-
man test for non-normally distributed data and subse-
quently by paired t-test for normally distributed data or
the Wilcoxon signed rank test for non-normally distrib-
uted data, where appropriate. Changes in FS (ALDS)
and QOL (VascuQol) scores between two subgroups of
limb salvage and major amputation (at baseline, 6, and
12 months), and differences between baseline scores for
the two subgroups lost to follow-up or complete follow-
up, were compared with the unpaired t-test or Mann-
Whitney test, where appropriate. The signiﬁcance level
was set at P < .05 and at P ¼ .025 to correct (Bonferroni)
for multiple testing of changes in FS and QOL over time.
All analyses were performed with SPSS 18.0 software
(SPSS Inc, Chicago, Ill).
RESULTS
Patients. Between May 2007 and May 2010, we
included 150 of 218 possibly eligible patients. Most
patients were men (96 [64%]) and mean (6 standarddeviation) age was 68.1 (6 12.4) years (Fig 2). Of these,
40 patients (27%) had ischemic rest pain, and 110 (73%)
had ischemic tissue loss. Baseline characteristics are pre-
sented in Table I. Table II reports the median baseline
scores for the ALDS (70.8; range, 11.8-89.2) and Vascu-
Qol sum (3.0; range, 1.1-5.9) and domain scores for the
150 included patients.
The primary treatments at study inclusion were endo-
vascular in 98 (65.3%), surgical in 36 (24.1%), conservative
in 11 (7.3%), or a major amputation in ﬁve (3.3%). Fig 3, A
shows the number of additional ipsilateral endovascular
and surgical interventions performed after the primary
intervention.
Outcomes. Of 150 patients at baseline, 112 completed
the ALDS and 111 ﬁlled in the VascuQol after 12 months.
Limb salvage was achieved in 98 patients (88%), whereas 14
(12%) underwent a major amputation (Fig 3, B). Table III
reports baseline and 6 and 12 months’ median ALDS and
VascuQol sum and domain scores for the total patient
group and for the two subgroups of limb salvage or major
amputation.
Patients lost to follow-up. No 12-month follow-up
ALDS and VascuQol data were available for 38 of 150
patients because 19 (13%) died and 19 (13%) were lost to
follow-up in #1 year. The main reasons for loss to follow-
up were withdrawal of consent and lack of compliance to
complete the questionnaires. None of these 19 patients
underwent a major amputation#1 year after inclusion, and
one patient died. Patients who did not complete the
questionnaires at 12 months had lower median baseline
Table I. Characteristics at baselinea
Demographics
Mean 6 SD or
No. (%) (n ¼ 150)
Age, years 68.1 6 12.4
Body mass index, kg/m2 25.8 6 4.9
Male sex 96 (64)
Diabetes mellitus 61 (41)
Hypertension 119 (79)
Hyperlipidemia
No 67 (45)
Yes 24 (16)
Unknown 59 (39)
Smoking
Current 55 (37)
Former 66 (44)
Never 29 (19)
Coronary heart disease 55 (37)
COPD 33 (22)
Previous TIA or stroke 35 (23)
Family history positive for CVD 74 (49)
Renal failureb 25 (17)
Previous treatment
Ipsilateral revascularizationc 54 (36)
Contralateral major amputation 9 (6)
Fontaine stage
Fontaine III 40 (27)
Fontaine IV 110 (73)
Ambulation
Level of walking at presentation
Inside and outside 98 (65)
Only inside 39 (26)
Wheelchair bound or bedridden 13 (9)
Residential status
Independent 140 (93)
Dependent 10 (7)
Self-reported walking distances
Pain-free, 0 m 78 (52)
Maximum <10 m 37 (25)
Median (range)
Examinations of symptomatic extremity
Ankle-brachial pressure index 0.46 (0.19-1.11)
Absolute toe pressure 34 (10-110)
Absolute TcO2 28 (1-53)
COPD, Chronic obstructive pulmonary disease; CVD, cardiovascular
disease; SD, standard deviation; TcO2, transcutaneous oxygen pressure; TIA,
transient ischemic attack.
aBefore intervention.
bDeﬁned as a serum creatinine >220 mmol/L.
cSurgical or endovascular.
JOURNAL OF VASCULAR SURGERY
960 Frans et al October 2013ALDS scores and lower VascuQol activity domain scores
than patients with complete follow-up (Table II).
FS. FS, expressed as median ALDS scores, signiﬁcantly
improved from 73 (range, 12-89) at baseline to 81 (range,
12-89) at 12 months. The median baseline ALDS score
before treatment was 73 (range, 22-89) for the 98 patients
who achieved limb salvage after 12 months and 69 (range,
12-89) for the 14 patients who underwent major amputa-
tion (P ¼ .493; Table III; Fig 4, A). These scores corre-
spond with easy outdoor activities (Supplementary Table,
online only). After 12 months, the median ALDS score hadincreased signiﬁcantly, from 73 to 83 (P ¼ .001), in
patients who achieved limb salvage. This corresponds with
more difﬁcult outdoor and indoor activities. In the major
amputation group, the median ALDS score decreased from
69 to 55 (P ¼ .117) after 12 months. This corresponds
with domestic activities only. At 6 and 12 months, the
ALDS scores for patients with limb salvage were signiﬁ-
cantly higher than scores for patients with a major ampu-
tation (P < .001 and P ¼ .007, respectively).
QOL. VascuQol scores improved signiﬁcantly in all
domains in all patients between baseline and at 12 months
of follow-up (Table III). The VascuQol sum scores
improved in the limb salvage group and in the major
amputation group after 6 and 12 months (Fig 4, B).
Furthermore, after limb salvage, the VascuQol scores
improved signiﬁcantly in all separate domains (P < .001;
Table III) After major amputation, there was a signiﬁcant
increase in all VascuQol scores, except for the activity and
social domains (Table III). The only signiﬁcant difference
at 6 and 12 months between the two subgroups of limb
salvage and major amputation was in the activity domain,
with a lower score for amputees (P ¼ .031 and P ¼ .009,
respectively).
DISCUSSION
This is the ﬁrst longitudinal study to use the ALDS to
evaluate changes in FS in patients who were treated for
CLI. Our study supports the applicability of the ALDS in
patients with CLI, conﬁrms the clinical validity, and shows
the good responsiveness of the ALDS. We think the ALDS
can be a useful instrument for daily practice to inform
patients on the expected level of daily life activities after
a successful intervention or failure to retain the lower
limb, because the ALDS expresses FS more precisely than
gross measures such as ambulation and residential status.
The ALDS is better suitable for patients with CLI
than previously applied more comprehensive instruments
such as the Katz or Barthel index.18,19 These indices are
not adapted to the disability level speciﬁc for patients
with CLI because they focus only on relatively simple
indoor activities such as bathing, continence, and feeding.
Evaluation of treatment outcome with the Katz and Bar-
thel index in patients with CLI is therefore not advocated
and may lead to erroneous conclusions, including that FS
is not improved by a successful revascularization.19
Furthermore, a major strength of the ALDS is that the
selected items can be adjusted to the performance level of
the population being studied. In a previous study, we
selected more difﬁcult activities from the ALDS question-
naire for patients with intermittent claudication than for
those with CLI.13 The clinical validity of the ALDS was
conﬁrmed in that study by the higher baseline ALDS scores
in patients with intermittent claudication.13
Patients and physicians are confronted with the
dilemma of whether to perform a primary amputation
instead of a long course with revascularization and long
time to complete wound healing. We had hopes that the
ALDS could serve as an aid in the decision of whether
Table II. Baseline Academic Medical Center Linear Disability Score (ALDS) and Vascular Quality of Life Questionnaire
(VascuQol) scores
Scores
Baselinea (n ¼ 150),
median (range)
Lost to follow-up (n ¼ 38),
median (range)
Complete follow-up (n ¼ 112),
median (range)
Difference lost vs complete
follow-up, Pb
ALDS 71 (12-89) 63 (12-89) 73 (12-89) .018
VascuQol
Sumscore 3.0 (1.1-5.9) 3.0 (1.4-4.3) 3.0 (1.1-5.9) .640
Activity 2.4 (1.0-6.6) 2.1 (1.0-4.1) 2.4 (1.0-6.6) .007
Symptoms 3.3 (1.0-7.0) 3.5 (1.5-6.0) 3.3 (1.0-7.0) .464
Pain 2.3 (1.0-7.0) 2.0 (1.0-7.0) 2.3 (1.0-7.0) .862
Emotional 3.6 (1.0-6.9) 3.5 (2.1-6.4) 3.6 (1.0-6.9) .862
Social 3.0 (1.0-7.0) 2.5 (1.0-6.5) 3.0 (1.0-7.0) .340
aBefore intervention.
bConsidering an independent sample t-test or Mann-Whitney test for differences between lost to follow-up or complete follow-up where appropriate, P < .05
indicates statistically signiﬁcant difference.
Fig 3. A, Primary and additional interventions. B, Details on limb salvage or major amputation. AKA, Above-knee
amputation; BKA, below-knee amputation; N/A, not applicable.
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could not in retrospect ﬁnd a threshold for the ALDS to
support decision making, because patients whose limbs
were amputated had similar ALDS baseline scores aspatients with a salvaged limb. Although it is desirable to
have an instrument to predict whether a patient beneﬁts
more from a primary amputation or revascularization,
this decision depends on multiple factors other than
Table III. Outcomes Academic Medical Center Linear Disability Score (ALDS) and Vascular Quality of Life
Questionnaire (VascuQol) scores
Outcomes
Total group
Difference
Limb salvage
B-6 months-
12 months B-12 months
B,a 6 months,b 12 months,c
Pd
B,a 6 months,b 12 months,c
median
(range)
median
(range)
median
(range)
median
(range)
median
(range)
median
(range)
ALDS (n ¼ 112) (n ¼ 98)
Score 73 (12-89) 78 (12-89) 81 (12-89) .007 .014 73 (22-89) 81 (31-89) 83 (12-89)
VascuQol (n ¼ 111) (n ¼ 98)
Sumscore 3.0 (1.1-5.9) 4.0 (1.2-6.7) 4.3 (1.6-6.8) <.001 <.001 3.0 (1.1-5.9) 4.2 (1.4-6.7) 4.3 (1.7-6.8)
Activity 2.4 (1.0-6.6) 3.4 (1.0-6.9) 3.6 (1.0-6.9) <.001 <.001 2.4 (1.0-6.6) 3.5 (1.3-6.9) 3.8 (1.3-6.9)
Symptoms 3.3 (1.0-7.0) 4.6 (1.0-7.0) 4.8 (1.5-7.0) <.001 <.001 3.4 (1.0-7.0) 4.8 (1.0-7.0) 4.8 (1.5-7.0)
Pain 2.3 (1.0-7.0) 4.3 (1.0-7.0) 4.3 (1.0-7.0) <.001 <.001 2.3 (1.0-7.0) 4.3 (1.0-7.0) 4.1 (1.0-7.0)
Emotional 3.6 (1.0-6.9) 4.4 (1.0-6.9) 4.7 (1.0-6.9) <.001 <.001 3.9 (1.0-6.9) 4.4 (1.3-7.0) 4.7 (1.4-6.9)
Social 3.0 (1.0-7.0) 4.0 (1.0-7.0) 4.5 (1.0-7.0) <.001 <.001 3.0 (1.0-7.0) 4.0 (1.0-7.0) 4.8 (1.0-7.0)
aBaseline, before intervention.
bFollow-up 6 months.
cFollow-up 12 months.
dConsidering a linear mixed model or the Friedman test for differences between baseline, follow-up at 6 months and at 12 months and a paired t-test or
Wilcoxon signed ranks test for differences between baseline and follow-up at 12 months where appropriate, P < .025 indicates statistically signiﬁcant
difference.
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making in patients with CLI might be aided by including
FS scores, such as the ALDS, but this needs further
investigation.
One of the aims of treating patients with CLI is to
improve their QOL. The VascuQol is the most frequently
used instrument to assess QOL in these patients. We noted
that the overall VascuQol improved in patients who
retained their leg and also in patients with an amputation.
The latter may be explained by a “response shift,” meaning
that the internal standards and values of the patients after
a major amputation change over time, and consequently,
their self-evaluation of QOL.20 This can lead to a situation
in which patients appear stable, but report a changing
QOL, or appear to be deteriorating, yet report an
unchanged QOL. The latter could be present with the
patients after major amputation.
What does recording FS add to recording VascuQol
scores? Zooming in on the scores on the activity domain
of the VascuQol shows that the mean improvement in
patients who retained their leg was 1.4 points. However,
the difﬁculty in the interpretation of such an improve-
ment in points is that this lacks a direct, clinically signiﬁ-
cant meaning.21,22 The ALDS carries the advantage that
scores correspond with the level of daily life activities,
which is easier to understand. There was no decrease in
the VascuQol activity domain scores in patients who
underwent an amputation. This may also be an example
of a response shift: a patient’s perception of his or her
level of activities has not changed despite the amputation.
A QOL instrument has not been designed to measure FS,but intends to measure patients’ perception of func-
tioning. A true difference in performance status may go
unnoticed, which is made clear by the lower ALDS scores.
These ﬁndings imply that the VascuQol questionnaire is
appropriate to detect changes in QOL, including the
activity domain, but that the VascuQol cannot be used
to evaluate the performance of activities after treatment
of patients with CLI.
Our study has limitations. We have to consider selec-
tion bias and nonresponse bias. Although we tried to
include all consecutive patients presenting at our vascular
surgery department, 68 patients (31%) did not participate
in our study (Fig 2). This was mostly due to cognitive
impairment, insufﬁcient knowledge of the Dutch
language (excluded patients), or the eventual burden to
attend two follow-up visits (patients who withdrew
consent).
Nonresponse bias was also present: 38 included patients
did not complete the questionnaires at the 12-month
follow-up because 19 (50%) had died and the other 19
were lost to follow-up. These patients had a lower baseline
FS than patients with complete follow-up assessments and
also had a lower QOL. We assume that the mean difference
in ALDS and VascuQol scores would have been less if
follow-up had been complete, because 18 of these patients
retained their leg. Selection bias and nonresponse bias limit
the external validity of our ﬁndings and indicate that the use
of patient-reported outcomes in research and clinical prac-
tice may be hampered by the frailty of CLI patients.
External validity may also be limited because we
conducted the study in a single academic hospital in The
Difference
Major amputation
Difference
B-6 months-
12 months B-12 months
B-6 months-
12 months B-12 months
Pd
B,a 6 months,b 12 months,c
Pd
median
(range)
median
(range)
median
(range)
(n ¼ 14)
<.001 .001 69 (12-89) 41 (11.8-89.2) 55 (16-89) .006 .117
(n ¼ 13)
<.001 <.001 2.6 (1.8-4.4) 3.6 (1.2-5.7) 4.2 (1.6-5.9) .004 .002
<.001 <.001 2.4 (1.3-4.3) 2.6 (1.0-5.5) 2.3 (1.0-5.4) .980 .610
<.001 <.001 3.3 (2.5-4.8) 4.0 (1.0-7.0) 5.0 (2.5-6.8) .007 .003
<.001 <.001 2.0 (1.0-3.5) 4.0 (1.0-6.5) 4.3 (2.3-6.8) .001 .001
<.001 <.001 3.3 (1.0-5.0) 4.1 (1.0-5.7) 4.3 (1.0-6.6) .002 .002
<.001 <.001 3.0 (1.0-7.0) 3.5 (1.0-7.0) 4.0 (1.0-6.5) .115 .105
Table III. Continued.
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surrounding hospitals, and therefore, more severe cases
could have been included. Results might differ in other
settings.
Second, we did not apply a generic QOL question-
naire, such as the Short Form-36,23 to measure health
status in this speciﬁc patient group in addition to the
disease-speciﬁc VascuQoL. We therefore remain ignorant
of the effect of CLI and its treatment on the general health
status of the patients individually and in relation to the
general population.
Third, we could have introduced social desirability bias
because the ALDS was interviewer-administered (by one of
us) in contrast to the VascuQol, which was self-completed
by the study participants. Yet, Puhan et al24 showed that
administration formats do not have a meaningful effect
on repeated measurements of patient-reported outcomes.
As a consequence, we did not need to consider the effect
of different administration formats in our analyses.24
Fourth, it might be that we did not ﬁnd a threshold for
the ALDS score to support decision making regarding
amputation because the study was underpowered to detect
such a difference. Yet, we could not perform a power calcu-
lation because we did not know if there would be any
differences in baseline ALDS scores and if so, to what
extent. Furthermore, we found wide ranges in VascuQol
and ALDS for patients with CLI, which may be attribut-
able to comorbid conditions that we did not record. Inclu-
sion of more comorbid conditions with a particular affect
on function and health perception could be highly informa-
tive and should be included in future studies.Finally, we included a heterogeneous group,
including those with newly diagnosed CLI and also those
who had undergone previous treatment for CLI. Because
the patient group was heterogeneous and the severity and
localization of symptoms were diverse, several patients
had been treated multiple times and at different time
points within the 12-month follow-up period. This could
have inﬂuenced the FS and QOL outcomes at the 6-
month and 12-month follow-up visits. Nevertheless,
this approach represents the normal course of patients
with CLI.
Furthermore, this study aimed to measure FS and
QOL in patients with CLI over time, not to compare
different treatment modalities in matched patient groups.
One might also argue that some of the physiologic metrics
do not ﬁt a CLI cohort. This may be partly explained by
the inclusion of diabetic patients with high ankle pressures
due to media calciﬁcation. CLI in these patients was
conﬁrmed by toe pressure measurement. Further substan-
tiating the presence of CLI was that almost none of the
included patients could be managed conservatively.
CONCLUSIONS
Our study conﬁrms the clinical validity of the ALDS in
patients treated for CLI and shows that it is a valuable and
sophisticated instrument to measure change in FS. With
regard to daily clinical practice, the ALDS may help to
inform patients about the expected level of performance
of daily activities after limb salvage or amputation. Further
studies should aim at whether the ALDS can also be
applied to compare FS among different cohorts of patients
Fig 4. Box plots show (A) Academic Medical Center Linear
Disability Scores (ALDS) and (B) Vascular Quality of Life
Questionnaire (VascuQol) sumscores at baseline and at 6 and
12 months after intervention. The horizontal line in the
middle of each box indicates the median; the top and bottom
borders of the box mark the 75th and 25th percentiles,
respectively, and the whiskers mark the range (minimum and
maximum).
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964 Frans et al October 2013and hospitals. If these studies support our ﬁndings, the
ALDS can be used to compare different and new treatment
modalities and assess differences in the effects of treatment
between hospitals.
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Supplementary Table (online only). The Academic Medical Center Linear Disability Score (ALDS) score for critical
limb ischemia
Are you able to .
I can carry out
the activity
I can carry out the
activity with difﬁculty
I cannot carry
out the activity
Not
applicable
Linear transformed
ALDS score
1. Vacuum a ﬂight of stairs? , , , , 87
2. Vacuum a room and move light furniture? , , , , 84
3. Fetch groceries for 3-4 days? , , , , 82
4. Travel by local bus or tram? , , , , 78
5. Go shopping for clothes? , , , , 73
6. Go to a party? , , , , 70
7. Hang and take in a load of washing? , , , , 69
8. Move a bed or table? , , , , 66
9. Walk up a ﬂight of stairs? , , , , 65
10. Go to the bank or post ofﬁce? , , , , 64
11. Walk down a ﬂight of stairs? , , , , 62
12. Cross the road? , , , , 58
13. Fetch a few things from the shop? , , , , 56
14. Have a shower and wash your hair? , , , , 50
15. Dust? , , , , 50
16. Clean a toilet? , , , , 48
17. Move between two low chairs? , , , , 42
18. Clean a bathroom sink? , , , , 42
19. Get in and out of a car? , , , , 39
20. Clear the table after a meal? , , , , 37
21. Prepare breakfast or lunch? , , , , 36
22. Wash up? , , , , 31
23. Make coffee or tea? , , , , 25
24. Put long trousers on? , , , , 24
25. Sit on the edge of a bed from lying down? , , , , 21
26. Get out of bed into a chair? , , , , 18
27. Go to the toilet? , , , , 17
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